» Articles » PMID: 26607500

Discordant Associations of Lipid Parameters with Albuminuria and Chronic Kidney Disease: a Population-based Study

Overview
Publisher Biomed Central
Date 2015 Nov 27
PMID 26607500
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although dyslipidemia is related to the pathogenesis of renal insufficiency, which routinely available lipid measure is more applicable in estimation of kidney function is still uncertain. Our objective was to evaluate inconsistent associations of lipid profiles with both albuminuria and chronic kidney disease (CKD).

Methods: We performed a population-based study in 9730 subjects aged 40 years or older. Definitions of abnormalities in albumin excretion were according to the latest guidelines of American Diabetes Association's Standards of Medical Care. CKD was defined as estimated glomerular filtration rate (eGFR) < 60 mL/min per 1.73 m(2) or the presence of albuminuria.

Results: There were 2274 (23.4%) participants categorized as low-grade albuminuria, 639 (6.6%) participants categorized as increased urinary albumin excretion and 689 (7.1%) participants categorized as CKD. Triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), Non HDL-C to HDL-C ratio, TG to HDL-C ratio were significantly correlated with urinary albumin to creatinine ratio (ACR), serum creatinine and eGFR (all P < 0.0001). Compare with other lipid parameters, TG to HDL-C ratio have shown the strongest correlation with increased odds of both increased urinary albumin excretion and CKD. No significant associations between lipid parameters and low-grade albuminuria were observed after adjustments for potential confounding factors.

Conclusion: Our study lends support to discordant associations of lipid parameters with albuminuria and renal function. TG to HDL-C ratio is a better marker than other routine lipid measures for identifying renal insufficiency and should be given more consideration in the clinical practice.

Citing Articles

Lipid metabolism disorders and albuminuria risk: insights from National Health and Nutrition Examination Survey 2001-2018 and Mendelian randomization analyses.

Wang Y, Li S Ren Fail. 2024; 46(2):2420841.

PMID: 39491271 PMC: 11536668. DOI: 10.1080/0886022X.2024.2420841.


Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and diabetic kidney disease in patients with diabetes in the United States: a cross-sectional study.

Pan J, Li C, Zhang J, Sun Z, Yu X, Wan Q Lipids Health Dis. 2024; 23(1):317.

PMID: 39334123 PMC: 11437633. DOI: 10.1186/s12944-024-02308-5.


Serum and Urine Metabolites and Kidney Function.

Yeo W, Surapaneni A, Hasson D, Schmidt I, Sekula P, Kottgen A J Am Soc Nephrol. 2024; .

PMID: 38844075 PMC: 11387034. DOI: 10.1681/ASN.0000000000000403.


Lipidomics Profiling Reveals Serum Phospholipids Associated with Albuminuria in Early Type 2 Diabetic Kidney Disease.

Ye S, Hu Y, Zhou Q, Zhang H, Xia Z, Zhao S ACS Omega. 2023; 8(39):36543-36552.

PMID: 37810655 PMC: 10552467. DOI: 10.1021/acsomega.3c05504.


Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes.

Bulum T, Tomic M, Vrabec R, Brkljacic N, Ljubic S Biomedicines. 2023; 11(8).

PMID: 37626738 PMC: 10452473. DOI: 10.3390/biomedicines11082242.


References
1.
Eknoyan G, Hostetter T, Bakris G, Hebert L, Levey A, Parving H . Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis. 2003; 42(4):617-22. DOI: 10.1016/s0272-6386(03)00826-6. View

2.
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G . Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003; 139(10):802-9. DOI: 10.7326/0003-4819-139-10-200311180-00007. View

3.
Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H . Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004; 110(1):32-5. DOI: 10.1161/01.CIR.0000133312.96477.48. View

4.
de Zeeuw D, Remuzzi G, Parving H, Keane W, Zhang Z, Shahinfar S . Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004; 110(8):921-7. DOI: 10.1161/01.CIR.0000139860.33974.28. View

5.
Go A, Chertow G, Fan D, McCulloch C, Hsu C . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351(13):1296-305. DOI: 10.1056/NEJMoa041031. View